Category: Regulatory/FDA

FTC to Pharma on Native Advertising: Proceed with Caution

Jury Says “Not Guilty” to Off-label Charges in Medical Device Case

Industry More Than Ready for FDA Off-label Communications Guidance

OPDP Enforcement Letter Cites Hospira for Omission of Risk in YouTube Video

Pacira Prevails in Exparel Settlement with FDA

Rocky Political Road Ahead for Pharma Industry

Kaiser Poll: DTC Ads Have High Profile, But Mixed Reviews

FDA Study of DTC Ads Reaches Critical Mass

Senate Bill Would Loop Nurse Practitioners and PAs into Sunshine Reporting